P

Inventor

BODMER MARK WILLIAM

GB12 patents
⚠️ This page may combine multiple inventors who share the name “BODMER MARK WILLIAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELLTECH THERAPEUTICS LTD

6 patents
US5994510ANov 30, 1999

Recombinant antibodies specific for TNFα

CELLTECH THERAPEUTICS LTD233 citations98
US5877293AMar 2, 1999

CDR grafted anti-CEA antibodies and their production

CELLTECH THERAPEUTICS LTD537 citations98
US5677425AOct 14, 1997

Recombinant antibody

CELLTECH THERAPEUTICS LTD1,026 citations97
US6180377B1Jan 30, 2001

Humanized antibodies

CELLTECH THERAPEUTICS LTD473 citations96
US5998586ADec 7, 1999

Interleukin-5 specific recombinant antibodies

CELLTECH THERAPEUTICS LTD17 citations92
US6316227B1Nov 13, 2001

Nucleic acids encoding interleukin-5 specific recombinant antibodies

CELLTECH THERAPEUTICS LTD9 citations73

CELLTECH LTD

2 patents
US5958413ASep 28, 1999

Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor

CELLTECH LTD197 citations95
US5965405AOct 12, 1999

Method for producing Fv fragments in eukaryotic cells

CELLTECH LTD34 citations92

CELLTECH R&D LTD

2 patents
US6734286B2May 11, 2004

Interleukin-5 specific recombinant antibodies

CELLTECH R&D LTD9 citations73
USRE39548EApr 3, 2007

Interleukin-5 specific recombinant antibodies

CELLTECH R&D LTD4 citations62

(unassigned)

1 patent
US6013642AJan 11, 2000

Use of estrone derivatives as steroid sulphatase inhibitors

19 citations84

SOLVAY

1 patent
US6315999B1Nov 13, 2001

Pharmaceutical product for the treatment of sepsis

SOLVAY12 citations69